Modulation of activity of the N-methyl-D-aspartate receptor as a novel therapeutic avenue in major depression: an immunohistochemical evaluation of the mechanism of action and the side-effects profile of rapastinel (GLYX-13) in the rodent brain

Ähnliche Einträge

• Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
  von: Vasilescu, Andrei-Nicolae, et al.
  Veröffentlicht: (2017)
• N-methyl-D-aspartate receptor: nitric oxide synthase pathway in the cortex of Nogo-A-deficient rats in relation to brain laterality and schizophrenia
  Veröffentlicht: (2013)
• Kinome expression profiling to target new therapeutic avenues in multiple myeloma
  von: Boussac, Hugues de, et al.
  Veröffentlicht: (2020)
• The challenge of finding new therapeutic avenues in soft tissue sarcomas
  von: Kasper, Bernd
  Veröffentlicht: (2019)
• N-Methyl-D-Aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis
  von: Sühs, Kurt-Wolfram, et al.
  Veröffentlicht: (2014)